How Business Fights the Feminization of Hiv/Aids
Total Page:16
File Type:pdf, Size:1020Kb
2007 HWHE CASE STUDIES IN GOOD COMPANY: HOW BUSINESS FIGHTS THE FEMINIZATION OF HIV/AIDS 2007 CASE STUDIES WHAT’S INSIDE • Executive Summary • 2007 Case Studies • Lessons Learned • Ways Forward • New Business Tools Cover image courtesy of Cora Meirowitz TABLE OF CONTENTS Table of Contents EXECUTIVE SUMMARY 2 CASE STUDIES BOEHRINGER INGELHEIM 4 EXXON MOBIL CORPORATION 7 HOME BOX OFFICE 10 EASTONE LLC 12 JOHNSON & JOHNSON 15 LEVI STRAUSS & CO. 18 MICATO SAFARIS 21 MTV NETWORKS INTERNATIONAL 24 STANDARD CHARTERED, PLC 27 SSL INTERNATIONAL 30 MAP 34 TOOLS 36 2007 CASE STUDY Executive Summary Nearly half of all people living with HIV/AIDS worldwide Corporations possess the expertise, resources, products are female. In the hardest hit countries in southern Africa, and services needed by the global health and over 60% of adults living with HIV are women, and young development community not only to reduce the burden of women aged 15-24 are three to four times more likely to be HIV/AIDS, but also to foster economic growth. EXECUTIVE SUMMARY HIV positive than their male counterpartsi. Women and girls Partnerships between the public and private sectors are form the backbone of their families and communities and key to creating sustainable, cost-effective HIV/AIDS shoulder the majority of care-giving responsibilities, yet efforts, offering innovative and adaptable solutions to often do not enjoy equal opportunities in education, ever-changing challenges like HIV/AIDS. employment, marriage and access to information. As such they bear a disproportionate share of the epidemic’s To increase business involvement in programs that psychological, economic, social and health burdens. To be specifically benefit women and girls, GBC leads the effective, business efforts to mitigate the impact of HIV/AIDS Healthy Women Healthy Economies (HWHE) initiative must focus on the special needs of women and girls. with support from the Nike Foundation, the David & Lucile Packard Foundation and FedEx. HWHE provides The Global Business Coalition on HIV/AIDS, Tuberculosis tools and guidance for the private sector in three crucial and Malaria (GBC) actively works to encourage and areas of the female vulnerability to HIV/AIDS: Economic support a strengthened business response to HIV/AIDS by Empowerment, Education for Girls and Sexual and leveraging the private sector’s pivotal skills and core Reproductive Health Services and Information. competencies to enhance advocacy, community outreach and workplace efforts. The feminization of HIV/AIDS is not only a health and humanitarian crisis, it is an international emergency that in most affected countries could damage economies if left unaddressed. HIV/AIDS markedly impacts economic and employment growthii– resulting in a loss of human capital, decreased production capacity due to worker absenteeism, and increased costs to train and replace the high turnover of staffiii. Females represent 41 percent of the world’s labor force living with HIViv and the percentage is even higher in developing economies and within agricultural, manufacturing, apparel and footwear sectorsv. In the global economy, where the developed world increasingly relies on the female workforce for imported goods, female vulnerability to HIV/AIDS could have the serious consequence of decreased economic growth. Research and experience show that females are critical to modern economic growthvi, and when their role as caregivers, householders and mothers of employees and consumers is factored in, it becomes clear that the health and well being of females is central to economic growth and development. 2 IN GOOD COMPANY: HOW BUSINESS FIGHTS THE FEMINIZATION OF HIV/AIDS EXECUTIVE SUMMARY There are many opportunities for business to ensure their Key Themes and Good Practices policies and community programs respond to the 1. Multi-sector partnerships and diverse collaboration feminization of HIV/AIDS. This publication: In Good including all levels of government Company: How Business Fights the Feminization of HIV/AIDS provides concrete examples of innovative 2. Business leadership and commitment for workplace and business practices that respond to the HIV/AIDS epidemic, community engagement identifies areas for collaboration and is intended to motivate other companies to join the response to the 3. Systems of effective monitoring & evaluation feminization of HIV/AIDS. The publication is part of a larger GBC effort to encourage business action to address 4. Community involvement the growing HIV/AIDS crisis among women and girls. These case studies are part of a broader HWHE toolkit, 5. Creative media such as art and sport to deliver which includes an online evidence base, tools for business information and education action and resources to facilitate partnerships between members companies and other stakeholders. 6. Activities in emerging economies and next-wave regions of the epidemic such as Eastern Europe and South Asia The featured programs in this publication highlight the Acknowledgements varied engagements worldwide by GBC member companies and recognize that HIV/AIDS must be GBC would like to thank the featured companies for addressed in all countries and across communities by participating in this publication and congratulate them on leveraging local expertise and resources via multi-sector their efforts: Boehringer Ingelheim, Exxon Mobil partnerships. Corporation, Home Box Office, Inc. (HBO), EastOne LLC, Johnson & Johnson, Levi Strauss & Co., Micato Safaris, In addressing the health, education and economic needs of MTV Networks International, Standard Chartered Plc. and women and girls, these companies demonstrate SSL International. Their work sets the stage for future innumerable ways to make important contributions to the collaboration, partnerships and programmatic possibilities HIV/AIDS response and to the communities in which they to protect the health of women and girls. work. Leaders from various sectors – financial services, apparel, healthcare, media & entertainment, metals, GBC would also like to salute its strategic partners, pharmaceuticals, travel & tourism, and energy – operating including the Nike Foundation, the David & Lucile across regions and in some of the hardest hit countries, Packard Foundation, FedEx, and the Global Coalition on including Angola, Kenya, Brazil, India, China, and Women and AIDS (GCWA), for their continued support Ukraine – show the crucial role business can play. and collaboration to catalyze efforts to address the feminization of HIV/AIDS. The diversity of these programs - in terms of scale, location and outcomes - demonstrates how different efforts can Editorial Note: The information for these case studies reduce the impact HIV/AIDS among women and girls, was provided by GBC member companies. thereby improving business productivity and mitigating the consequences of the feminization of the epidemic. i [0] UNAIDS, “AIDS Epidemic Update,” December 2007. ii Harvard Business Review, “AIDS Is Your Business,” February 2003. Opportunities to respond include: donations of medicines iii TD Bank Financial Group, “TD Economics Special Report: The Economic Cost of to prevent mother to child transmission of HIV; AIDS: A Clear Case for Action,” August 2006. iv World Economic Forum, “Business and HIV/AIDS in Africa: A Regional Snapshot,” strengthening the infrastructure of schools and health 2005. services within communities in Sub-Saharan Africa; v Business for Social Responsibility, “Women’s General & Reproductive Health in Global Supply Chains,” October 2006. promoting social marketing initiatives on condom use and vi The World Bank, “Gender Equality and Economic Development: The Role for male behavior change. The options to get involved are Information and Communication Technologies,” April 2004. wide-ranging and benefit from the innovation, creativity and efficiency that only the private sector can offer. For more information, please contact Shana Ward Ryzowy, Healthy Women Healthy Economies at [email protected] 3 2007 CASE STUDY Boehringer Ingelheim BUSINESS OVERVIEW Boehringer Ingelheim began the Viramune® Donation Founded in 1885, the Boehringer Ingelheim group is one Programme in order to help meet the needs of HIV-positive of the world’s 20 leading pharmaceutical companies. With pregnant women in developing countries during delivery and headquarters in Ingelheim, Germany, it operates on a decrease the risk of transmission of HIV to babies. Viramune® global scale with 137 affiliates in 47 countries. The (nevirapine) is an anti-retroviral drug developed by company is involved in basic research and is committed to Boehringer Ingelheim that helps prevent HIV infection from BOEHRINGER INGLEHEIM improving HIV therapy by providing physicians and mothers to babies during birth. A single Viramune® tablet patients with innovative anti-retrovirals (ARVs). taken by the mother during labor, and a dose of Viramune® suspension given to the baby within the first 72 hours of birth, In 2006, Boehringer Ingelheim spent one fifth of net sales in can reduce the rate of transmission of the virus by Prescription Medicines – its largest business segment – on approximately 50%. Through the Viramune® Donation research and development. The company is contributing to Programme, Boehringer Ingelheim aims to donate the drug for the fight against HIV/AIDS in the developing world use within the broader context of comprehensive pMTCT through various activities that all serve the ultimate goal of programs. To date, over 1 million doses